Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 14, 2005
[The outcome analysis of different treatment regimens in 206 patients with multiple myeloma]Yu-Jie Mai, Rui Li, De-Hui Zou, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 6, 2013
[Outcomes of younger than 60 years old adults with Ph/BCR-ABL positive acute lymphoblastic leukemia: a single center clinical trial of BDH ALL 2000/02]Yan-ru Zhang, Ting-yu Wang, De-hui Zou, et al.Chinese Journal of Cancer|June 11, 2015
Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survivalKai-Lin Chen, Jie Chen, Hui-Lan Rao, et al.Chinese Medical Journal|January 17, 2017
Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic LeukemiaHeng Li, Shu-Hua Yi, Wen-Jie Xiong, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 1, 2013
[Clinical and laboratory features of T-cell prolymphocytic leukemia in China]Yan-ru Zhang, Jun-yuan Qi, Hui-min Liu, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 9, 2004
[Second allogeneic transplant for leukemia relapsed after first allogeneic transplantation]Dong-lin Yang, Ming-zhe Han, Si-zhou Feng, et al.Blood Advances|March 6, 2019
Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective studyXiao-Qi Qin, Gang An, Zeng-Jun Li, et al.Blood Advances|February 24, 2026
Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adultsYan Xie, Ke-Shu Zhou, Lan-Fang Li, et al.Age and Ageing|October 21, 2021
Comprehensive geriatric assessment in newly diagnosed older myeloma patients: a multicentre, prospective, non-interventional studyYuan Yao, Wei-Wei Sui, Ai-Jun Liao, et al.European Journal of Haematology|May 19, 2020
IgH translocation with undefined partners is associated with superior outcome in multiple myeloma patientsXue-Han Mao, Jun-Ling Zhuang, Duo-Duo Zhao, et al.Pageof 6